The commercialization phase does not provide another allocation of SBIR money, so transition planning needs a distinct source of capital or purchasing demand.
A company approaching the end of an SBIR development project needs to explain who will finance what comes next. Describing the next stage as Phase III does not answer that question.
The SBA's phase overview, reviewed on 6 September 2026, describes Phase III as commercialization building on earlier work and states that it does not use SBIR or STTR funding. The practical implication is that a transition plan needs a distinct source of purchasing demand or investment. The STTR partner and intellectual property review connects the research arrangement with rights and responsibilities for the later product.
Management should identify what it expects to sell or finance after the research. Possibilities include a customer deployment, further development funded through another source, manufacturing investment or a commercial investment round.
These transactions have different decision makers and evidence requirements. A customer may need a supported product and a procurement path. An investor may need evidence that several customers will buy. A manufacturing investment may require a credible demand schedule and a stable design. The Other Transaction research, prototype and production comparison asks what work the agreement is actually buying.
A transition plan that groups them together under “commercialization” can conceal which dependency is most urgent.
For a hypothetical inspection system, successful research might establish detection performance under controlled conditions. A prospective purchaser may still need integration with its maintenance process, operator training and an agreed support arrangement. A further customer decision is still needed in the DIU prototype to production analysis after a prototype succeeds.
The company should identify those requirements before the research period ends. Some can be addressed through ordinary customer discovery and product planning. Others require additional funded work or decisions outside the company's control.
This does not mean the research award must deliver every feature of the eventual product. It means management should know what remains and avoid presenting the research milestone as complete purchasing readiness.
A bridge investment can keep engineers working while a customer evaluates the product. It is not customer revenue. Likewise, a letter expressing interest does not fund the next development period.
The cash plan should show the timing of contracted payments, committed investment and conditional opportunities separately. If the business depends on a purchase that has not been approved, the runway calculation should expose that dependency.
A useful scenario analysis asks what happens if the next purchase arrives later, at a smaller scope or after additional qualification work. The answers can change hiring, inventory and support decisions today.
Commercialization can involve several transactions that should be described separately. A customer may buy a ready product or fund a defined adaptation. An investor may provide capital to develop the business. A manufacturing partner may support production under a negotiated arrangement. Each has its own decision process, evidence requirements and commercial terms. Calling all of them Phase III does not explain which one the company is actually pursuing.
For a hypothetical inspection-system business, an initial customer deployment could require a product configuration, installation work and support. A separate investment round might finance manufacturing capacity or a broader sales team. The customer purchase and the investment can reinforce one another, but they are not interchangeable sources of cash. Management should identify the amount, timing and conditions associated with each rather than treating interest from one party as evidence that the other transaction is secured.
BDI's suggested transition note starts with the next deliverable. What would the company provide, to whom, and what decision would create the commitment? Then identify the work needed to reach that point. This makes the funding requirement concrete enough to discuss with customers and investors. It also exposes whether the business is seeking capital for a product it can already sell or for further development whose commercial outcome remains uncertain.
A customer evaluating the result of funded research needs to understand what it can use. The company should prepare an account of the demonstrated capability, the conditions under which it was assessed and the work that remains for deployment. The research result can be strong evidence while still leaving integration, training or support questions open. Identifying those questions early gives the team time to develop a credible next offer.
A hypothetical software product may have demonstrated a useful analytical function during the project. A prospective purchaser may need a supported service that fits an existing workflow and can be maintained by a defined team. The transition plan should explain the work connecting those two states. It should also identify which customer inputs are necessary, such as appropriate data access or participation in a permitted evaluation. Those dependencies affect both timing and the scope the company can price.
The company can use ordinary customer discovery to improve that plan without promising an award or requesting access outside the authorized process. The relevant questions concern the buyer's task, the proposed product and the decision needed for adoption. A clearer understanding of those issues helps management choose what to prepare before the research period ends and what requires a separately funded next stage.
The end of a research award can create a financing gap if the next transaction takes longer than expected. Management should model the company's own cash position using the payment conditions it actually has. A potential follow-on purchase belongs in a conditional scenario until the relevant commitment is established. This keeps the operating plan connected to evidence while still allowing the team to pursue an ambitious transition.
A practical scenario review can examine a delayed customer decision, a smaller initial deployment and additional product work requested before purchase. These are planning scenarios, not predictions about any particular award. Their value is to show which commitments the company can sustain and which should depend on later evidence. Hiring and inventory decisions become easier to assess when the timing assumptions are explicit.
The review should distinguish reusable work from customer-specific work. A product improvement that benefits several likely buyers may justify a different investment than an adaptation tied to one uncertain account. Management can evaluate both, but it should understand the concentration of the risk. Research success creates options; the transition plan determines how the business finances the options it chooses to pursue.
The company should retain the history of the funded effort in a form that later reviewers can understand. Identify what was developed, which milestones were completed and the evidence supporting the result. Preserve the relevant agreements and rights information with the people responsible for the commercial review. The public product story can remain concise while the underlying records support a more detailed customer or contracting discussion.
That preparation is especially useful when the next buyer did not sponsor the original research. It allows the company to explain the provenance and scope of the technology without assuming the reader knows the earlier project. The buyer can then assess relevance to its own requirement. Any specific acquisition route still needs review under the governing documents and the transaction being proposed.
A stronger transition narrative follows the evidence from research to product to customer decision. It explains what is ready, what remains to be done and who could fund or purchase the next stage. That gives founders a more actionable plan and gives prospective investors or partners a clearer account of how the technology could become a sustainable business.
The company should retain a clear account of what was developed, what was demonstrated and which rights and obligations apply. Future customers need to understand the product, while contracting discussions may need the history of the prior effort.
The relevant agency and contract documents govern any specific Phase III acquisition route. This article does not establish a company's entitlement to a follow-on award.
The commercial task is broader and immediate: identify a buyer or capital source, define the next deliverable and understand the conditions for commitment. Phase III can describe the stage of development, but a viable transition depends on those concrete decisions being made.
Public official pages reviewed on 6 September 2026. Commercial recommendations and hypothetical examples are BDI analysis. No specific open call, negotiated agreement or guaranteed transition is established.
Suggest a correction